Cargando…
An Experimental Pipeline for Initial Characterization of Bacterial Type III Secretion System Inhibitor Mode of Action Using Enteropathogenic Yersinia
Dozens of Gram negative pathogens use one or more type III secretion systems (T3SS) to disarm host defenses or occupy a beneficial niche during infection of a host organism. While the T3SS represents an attractive drug target and dozens of compounds with T3SS inhibitory activity have been identified...
Autores principales: | Morgan, Jessica M., Lam, Hanh N., Delgado, Jocelyn, Luu, Justin, Mohammadi, Sina, Isberg, Ralph R., Wang, Helen, Auerbuch, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262202/ https://www.ncbi.nlm.nih.gov/pubmed/30524970 http://dx.doi.org/10.3389/fcimb.2018.00404 |
Ejemplares similares
-
Innate Immune Recognition of Yersinia pseudotuberculosis Type III Secretion
por: Auerbuch, Victoria, et al.
Publicado: (2009) -
Editorial: The Pathogenic Yersiniae–Advances in the Understanding of Physiology and Virulence, Second Edition
por: Francis, Matthew S., et al.
Publicado: (2019) -
Chromosomally-Encoded Yersinia pestis Type III Secretion Effector Proteins Promote Infection in Cells and in Mice
por: Schesser Bartra, Sara, et al.
Publicado: (2019) -
Piericidin A1 Blocks Yersinia Ysc Type III Secretion System Needle Assembly
por: Morgan, Jessica M., et al.
Publicado: (2017) -
A ParDE toxin–antitoxin system is responsible for the maintenance of the Yersinia virulence plasmid but not for type III secretion-associated growth inhibition
por: Schott, Saskia, et al.
Publicado: (2023)